Overview
SLU-PP-332 is a synthetic small molecule that functions as a potent and selective pan-agonist of estrogen-related receptors (ERRα, ERRβ, and ERRγ). It has been studied for its potential to enhance mitochondrial function, increase energy expenditure, and improve metabolic health in preclinical models. This compound is provided exclusively for laboratory research purposes and is not intended for human consumption, medical use, or diagnostic applications.

Research Focus
In preclinical and laboratory studies, SLU-PP-332 has been investigated in relation to:

• Mitochondrial function – enhancing mitochondrial respiration and biogenesis in skeletal muscle cell lines.

• Metabolic regulation – increasing fatty acid oxidation and improving insulin sensitivity in animal models.

• Exercise-mimetic effects – inducing metabolic pathways involved in endurance training without actual physical exercise.

• Obesity and metabolic syndrome – reducing adiposity and improving glucose tolerance in diet-induced obese mice.

Key Features

• Potent pan-ERR agonist with EC₅₀ values of 98 nM (ERRα), 230 nM (ERRβ), and 430 nM (ERRγ)

• Enhances mitochondrial function and cellular respiration in skeletal muscle cell lines

• Increases energy expenditure and fatty acid oxidation in preclinical models

• Reduces fat mass and improves insulin sensitivity in metabolic syndrome models

• Supplied in lyophilized powder form for laboratory stability

• Manufactured to high-purity standards (≥98% HPLC)

Specifications

• Chemical Name: (E)-4-Hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide

• Molecular Formula: C₁₈H₁₄N₂O₂

• Molecular Weight: 290.32 Da

• CAS Number: 303760-60-3

• Purity: ≥98% (HPLC)

• Form: Tablets

• Intended Use: Research use only. Not for human consumption, medical, or veterinary use.

Disclaimer
This material is supplied for laboratory research purposes only. It is not a drug, food, or cosmetic. The buyer assumes all responsibility for safe handling and lawful use.